Who's paying for new drugs?

Drugs for Rare Diseases: Paying for Innovation

Whos In the Picture

The context in which a name appears in a caption provides powerful cues as to who is depicted in the associated image. We obtain 44,773 face images, using a face detector, from approximately half a million captioned news images and automatically link names, obtained using a named entity recognizer, with these faces. A simple clustering method can produce fair results. We improve these results s...

Paying more when paying for others.

Social behavior is heavily influenced by the perception of the behaviors of others. We considered how perceptions (and misperceptions) of kindness can increase generosity in economic transactions. We investigated how these perceptions can alter behavior in a novel real-life situation that pitted kindness against selfishness. That situation, consumer elective pricing, is defined by an economic t...

Paying for Performance in Healthcare Organisations

Aligning Financial Incentives (FIs) to health policy goals is becoming increasingly popular. In many cases, such initiatives have failed to deliver anticipated benefits. Attributing this to the actions of self-interested and resistant professionals is not an entirely helpful approach. It is important to avoid simplistic assumptions to build knowledge of how and why schemes are implemented in pr...

New WHO antenatal care model-quality worth paying for?

2574 www.thelancet.com Vol 388 November 26, 2016 The 2016 WHO guidelines on antenatal care were published earlier this month and are widely welcomed because they are not only academically robust, but also relevant to end-users and patients. The guidelines cover antenatal care for normal pregnancies and have adopted a woman-centred, holistic approach to care. They cover nutritional interventions...